DSL Media & Leadership

    Reliq & DSL: Understanding the July 2022 Go-Live Announcement

    Data Soft Logic (DSL) · Company editorial ·

    Written for: DSL clients, prospective agency partners and healthcare software buyers.

    What Reliq’s reported first-client milestone establishes—and what agencies should verify today.

    Announcement date: July 19, 2022

    Source: Reliq via GlobeNewswire
    Data Soft Logic company branding

    The source and its historical context

    In July 2022, Reliq Health Technologies reported that its first client through the DSL partnership had gone live and that onboarding had begun. The original GlobeNewswire release is dated July 19, 2022.

    What this does—and does not—establish

    The milestone is attributed to Reliq, not independently audited by DSL’s editorial team. It does not establish broader adoption, achieved growth forecasts, patient outcomes or current iUGO Care availability. No client identity or agency counts are reproduced.

    Why the topic matters to agency leaders

    A reported go-live is different from a general availability commitment. Agency leaders should evaluate the current service scope, support ownership and operational readiness rather than extrapolating from a historical milestone.

    Questions for your agency’s next conversation

    • What is available now, rather than what was announced in 2022?
    • Who supports the agency if a handoff between systems fails?
    • What validation and readiness steps are agreed before a new go-live?

    Current DSL context

    DSL provides software for home health, hospice and therapy organizations. Olympus Cloud handles eligibility, claim submission and remittance. HHC Verify Centre supports EVV, GPS check-in/out and offline charting with sync. Confirm availability and configuration for your agency in a tailored demonstration.

    AI-assisted documentation requires clinician review and approval; DSL does not provide AI coding or guarantee coding accuracy. Historical references do not establish present integration availability, clinical outcomes or regulatory compliance.

    Editorial attribution

    This is original DSL company commentary, published November 16, 2026—not independent reporting or republication of the linked source. No source excerpts, publisher artwork or award badges are reproduced. Excerpts remain unpublished until reuse permission is confirmed.

    Next step

    See how DSL handles this on a walkthrough tailored to your agency.